跳至主要内容
临床试验/CTRI/2014/08/004882
CTRI/2014/08/004882招募中4 期

To compare the efficacy of topical 0.1% tacrolimus ointment and pimecrolimus 1% cream in Vitiligo.

TANVI SINGH BHADORIA0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Less than 20 % body surface area involvement in patients with vitiligo
  • Patients having vitiligo not on any other treatment for last 4 weeks

排除标准

  • Involvement of more than 20% body surface area in patients with vitiligo
  • Immunocompromised patients
  • History of skin cancers or lymph proliferative disorders
  • Pregnant or lactating women
  • Patients on any other treatment for last 4 weeks
  • Netherton syndrome
  • Drop outs from the study

研究者

发起方
TANVI SINGH BHADORIA

相似试验